NA
PAHC icon

Navellier & Associates’s Phibro Animal Health PAHC Stock Holding History

Navellier & Associates’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Buy
52,340
+5,068
+11% +$241K 0.3% 79
2025
Q4 		$1.77M Sell
47,272
-4,354
-8% -$177K 0.2% 110
2025
Q3 		$2.09M Buy
51,626
+7,855
+18% +$259K 0.21% 109
2025
Q2 		$1.12M Sell
43,771
-1,172
-3% -$25.6K 0.14% 129
2025
Q1 		$878K Buy
+44,943
New +$1M 0.12% 147
2015
Q3 		– Sell
-7,000
Closed -$273K – 365
2015
Q2 		$273K Buy
+7,000
New +$241K 0.02% 296

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Navellier & Associates's PAHC Position: Q1 2026 in Review

Navellier & Associates increased its Phibro Animal Health (PAHC) stake by 11% in Q1 2026, buying an estimated $241K and bringing the position to 52,340 shares worth $2.89M. The position accounts for 0.3% of the portfolio, ranked #79.

Navellier & Associates first reported a position in PAHC in Q2 2015 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Navellier & Associates held 52,340 shares of Phibro Animal Health worth $2.89M as of Q1 2026.
  • Navellier & Associates bought 5,068 Phibro Animal Health shares in Q1 2026, an estimated $241K.
  • Phibro Animal Health made up 0.3% of Navellier & Associates's portfolio in Q1 2026, its #79 holding.
  • Navellier & Associates first reported a position in Phibro Animal Health in Q2 2015 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.